Compare FOA & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOA | STXS |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.7M | 210.0M |
| IPO Year | N/A | 2004 |
| Metric | FOA | STXS |
|---|---|---|
| Price | $24.76 | $2.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $29.75 | $4.00 |
| AVG Volume (30 Days) | 146.4K | ★ 614.4K |
| Earning Date | 03-10-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $318,296,000.00 | $30,075,000.00 |
| Revenue This Year | $29.44 | $24.21 |
| Revenue Next Year | $14.30 | $29.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.62 |
| 52 Week Low | $16.58 | $1.54 |
| 52 Week High | $29.58 | $3.59 |
| Indicator | FOA | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 60.79 | 63.06 |
| Support Level | $23.93 | $2.47 |
| Resistance Level | $24.94 | $2.86 |
| Average True Range (ATR) | 1.06 | 0.13 |
| MACD | 0.17 | 0.04 |
| Stochastic Oscillator | 76.54 | 76.42 |
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.